A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Korean Journal of Hematology
;
: 225-228, 2012.
Article
in English
| WPRIM
| ID: wpr-720322
ABSTRACT
Radioiodine is regularly used in the treatment of thyroid cancer to eliminate residual malignant tissue after thyroidectomy and to treat metastasis. Because of the low dose of radioiodine used to treat thyroid cancer patients, leukemia is an uncommon complication of exposure to radioiodine. Here, we present a patient who developed therapy-related acute myeloid leukemia with inv(16)(p13.1q22);CBFbeta-MYH11, eosinophilia, and K-ras mutation and who had been treated with very low-dose radioiodine following total thyroidectomy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thyroid Gland
/
Thyroidectomy
/
Thyroid Neoplasms
/
Leukemia, Myeloid, Acute
/
Leukemia
/
Oncogene Proteins, Fusion
/
Eosinophilia
/
Neoplasm Metastasis
Limits:
Humans
Language:
English
Journal:
Korean Journal of Hematology
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS